tirzepatide cardiovascular trial Effects of on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT Tirzepatide vs Dulaglutide for Cardiovascular

No published clinical trials support twice-weekly tirzepatide dosing

Additional information Supplementary Information accompanies the paper on the Translational Psychiatry website Supplementary information Rights and permissions This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License

Mechanistic studies in aged mice have revealed that D+Q triggers apoptosis in senescent hepatic progenitor cells, effectively reducing senescence-associated phenotypes including reduced SA--gal activity and clearance of p16INK4a-positive cells in the liver (186)

Neuron 86, 883901

10.3390/nu17182930 Nutrients